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Clinical picture of the amyloid arthropathy in
patients with chronic renal failure maintained
on haemodialysis using cellulose membranes
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From the Departments of 'Rheumatology and 2Pathology, Hospital Clinico y Provincial, Barcelona, Spain
SUMMARY The clinical picture of 15 patients (10 male, five female) with amyloid arthropathy
secondary to chronic renal failure treated with haemodialysis has been studied. The average
period of haemodialysis was 10-8 years. Joint symptoms appeared between three and 13 years
after starting haemodialysis. No patient had renal amyloidosis. Early symptoms were varied and
often overlapped: knee swelling (seven patients), painful and stiff shoulders (seven), and carpal
tunnel syndrome (six) were the most prominent. Follow up showed extension to other joints.
Joint effusions were generally of the non-inflammatory type. Radiologically, geodes and erosions
of variable sizes were seen in the affected joints, which can develop into a destructive
arthropathy. Amyloid was found in abdominal fat in three of the 12 patients on whom a needle
aspiration was performed. Four of 12 patients showed changes compatible with amyloid
infiltration in the echocardiogram. One patient had amyloid in the gastric muscular layer,
another in the colon mucus, and two of four in rectal biopsy specimens. Amyloid deposits showed
the presence of 32 microglobulin in 10 patients. The clinical and radiological picture was similar
to the amyloid arthropathy associated with multiple myeloma. These patients can develop
systemic amyloidosis.
Key words: 132 microglobulin, systemic amyloidosis.
The range of joint disease'-3 in patients with chronic
renal failure treated with periodic haemodialysis
(CRFH) has recently been increased by the descrip-
tion of new clinical entities which include a destruc-
tive spond loarthropathy47 and an erosive
arthropathy, "' both of unknown origin. In 1985 we
reported the presence of an amyloid type of
arthropathy in such patients.'" This has also been
described by other authors after fractures of the
femoral neck, 12-14 destructive hip arthropathy in
two patients needing surgery,'5 and in one patient
with ankle synovitis. In our initial study we found a
high percentage of patients had amyloid in the joint
effusions as well as in the synovial membrane.
Owing to the sensitivity and reproducibility of
amyloid measurement we concluded that the finding
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of amyloid in joint fluid was sufficient evidence for
the diagnosis of synovial amyloidosis.'16
A group of patients with CRFH and proved
amyloidosis (in synovial tissue or synovial fluid) has
been studied in order to evaluate their clinical and
radiological features.
Patients and methods
A group of 15 patients (Table 1) with CRFH and
persistent swelling in one or several joints in whom
synovial amyloidosis was confirmed by means of
synovial biopsy (eight patients) and synovial fluid
examination (seven patients) has been reviewed.
The aetiology for their chronic renal failure was:
glomerulonephritis (three patients), backflow hyd-
ronephrosis (one), nephroangiosclerosis (one),
chronic nephritis (two), polycystic disease (four),
and unknown (four). No patient had renal amyloido-
sis. Haemodialysis was performed by means of an
artificial kidney with automatic supply, continuous
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flow, and without capillary re-use. Cuprophane
membranes were used.
The follow up time was 3-3 years (range 0-5-6)
from the time the patient was first seen and 1.5 years
(range 0()15-2-5) from the time the diagnosis was
made. Patients were seen every three to four months
from the time of the first visit.
A detailed clinical history was taken of all the
patients, and they underwent a full clinical and
radiological examination with special emphasis on
the locomotor system. An echocardiographic ex-
amination was performed in most patients. Their
joint fluid was examined on various occasions
(leucocyte count. search for crxistals bv reguliar and
compensated polarised light microscopy both in
fresh synovial fluid and after alizarin red staining).
Amyloid was sought in joint fluid from all cases, in
synovial tissue biopsy specimens from eight patients.
in the abdominal fat of 12 patients. and in the liga-
ment or carpal tunnel structures, or both, in 12
patients with carpal tunnel svndrome who had
undergone surgery (bilateral in eight patients).
Svnovi al samples were fixed in 10% formol. and
synovial fluid sediments (after centrifugation) were
embedded in paraffin, stained with Congo red, and
studied under polarising microscopy. seeking the
green birefringence typical of amvloidosis. 17 Most of
the samples were treated with potassium perman-
ganate by Wright's technique.'8 In 10 patients we
carried out a histochemical analysis with the avidin-
biotin-peroxidase complex (ABC) technique. After
deparaffination and blockage of endogenous perox-
idase and tissular biotin. sections were treated with
rabbit antihuman V3, microglobulin antibody
(DAKO) at 1/600 dilution. The secondarv antiserum
used was biotin-swine antirabbit IgG (Vectastain).
Thereafter sections were treated with the avidin-
biotin-peroxidase complex (Vectastain). Sections
from kidney, adrenal gland. and carpal tissues from
patienLs with primary and secondary amvloidosis
and from the thvroid gland of a patient with known
medullarv carcinoma and amvloidosis were used as
controls. Additional control tests were performed,
replacing the primarv antiserum by phosphate
buffered serum.
Results
The 15 patients (10 male. five femnale), aled 35 to 69
vears (menan 58). hiad undergone periodic haeemo-
dialysis for 7 to 16 vears (mean 10(8). Joint
svmptoms appeared between 3 and 13 vears (mean
7) after haemodialvsis started.
Fig. I Patient No 11. Swelling of both shoulderA.
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Table 2 Ear/y symptoms
Carpal tunnel syndrome 2'
Carpal tunnel syndrome, knee
pain or swelling, or both 4
Shoulder pain 3
Ankle and shoulder pain and
knee swelling
Knee swelling I
Ankle swelling
Shoulder swelling
Cervical and shoulder pain
CLINICAL MANIFESTATIONS (Fig. 1)
Early symptoms were varied and often overlapped.
Knee swelling (seven patients), painful and stiff
shoulders (seven patients). and carpal tunnel syn-
drome (six patients) were the most prominent
(Table 2). The clinical articular picture had evolved
over a two to six year period (mean four years),
showing an extension to other joints during the
follow up (Table 3).
The shoulders (14 patients), knees (13 patients).
and the median nerve (13 patients) were the most
frequently affected areas, often bilaterally. In pa-
tients with shoulder pain but without swelling there
was always restricted mobility. Joint swelling was
persistent in most of the patients. with total remis-
sion in certain joints in a few patients after several
months of evolution. In general the symptoms were
well tolerated, occurring with little or no pain and
seemed to be caused by the capsular distension that
accompanied significant effusions. One patient with
chronic swelling of the shoulders, knees, and elbows
suffered from occasional acute crisis requiring
admission to hospital and synovial fluid culture to
rule out the possibility of an infectious arthritis. The
most troublesome symptoms affected the shoulders.
whether or not swollen, and the sensory distribution
area of the median nerve. Two patients of the series
had a spontaneous femoral neck fracture, one with
massive deposition of amyloid in synovial mem-
brane and capsule.
Table 3 Clinical simptoms; etnd of followt, lip
Utilolttr(il Bil(OCrOl il T)tal Joint011 iih
*~~~~~~~~~~~~~~~~~~~~(tlOlrl,si%
Shouldcrs 3 11 14 12/ 1 3
Knecs 4 9 13 21/1
Wrists 2I 7 91(0
Finger tcnosvnoviltls 3 4 7 11/0)
Anklcs 5 5 8/2
[lips 3 4 (0/7
Elbows 2 2 4/0)
Carpal tunncl ssndrome 3 10 13
JOINT FLUID
Cell counts varied from 0. 1 x 109/1 to 9 4 x 10)/l
(mean 1-4 x 109/1), excluding the patient with acute
crisis (mean 32 x 109/1). Crystals were not observed
in any of the fluids, either in the unstained prepara-
tion or after alizarin red staining.
RADIOI OGY
The radiological changes included geodes of vari-
able sizes and in some cases marked erosions (Figs 2
and 3, Table 4). Shoulder changes were the most
frequent (17/24). showing in most of the cases a
radiolucent defect of variable size (largest diameter
4-10 mm), round or oval, and surrounded by a
(1sr
Fig. 2 Patient No 2. Cvst lesions in several carpal bones,
especially in the pro.rimal end of the third metacarpal,
scaphoid, and capitate.
Fig. 3 Patient No 4. Cyst lesions in the right femoral head
and acetabiulum.
ol
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sclerotic halo of variable thickness (Fig. 4). It was
localised in the epiphyseal region between the
anatomic and surgical necks. Normally there was
only one radiolucent lesion present, two being
observed in a few patients.
Bone erosion was very obvious in six shoulders
(diameter larger than 5-13 mm), and in one case this
was accompanied by similar lesions in the glenoid
area.
Apart from the classical radiological picture of
hyperparathyroidism or renal osteodystrophy, or
both, present in some of our patients, alterations
consistent with erosive spondyloarthropathy were
found in four patients (No 7: L5-S1; No 9: C4-C5,
C5-C6; No 11: C5-C6 (Fig. 5); No 13: C4-C5,
C5-C6, D6-D7, D7-D8). The localisation of the
amyloid deposits is shown in Table 5. Needle
aspiration of abdominal fat was performed in 12
patients, being negative for amyloid in nine and
positive in three patients. Four of 12 patients
without cardiac symptoms showed changes com-
Table 4 Radiological changes
Unilateral Bilateral No of
patients x rayed
Shoulders 3 7 12
Wrists 4 5 14
Fingers 2 2 14
Knees 3 3 12
Hips 4 14
Ankles 1 1 5
Elbows 1
patible with cardiac amyloid infiltration when
studied by means of echocardiography. Immuno-
histochemical analysis proved the presence of 12
microglobulin in 10 patients: synovial fluid sediment
(six patients), synovial membrane (five patients),
f
Fig. 5 Patient No 11. Erosive spondyloarthropathy at the
C5-C6 level.
Fig. 4 Patient No 9. Oval and rounded radiolucent
images surrounded by a sclerotic halo in left shoulder.
.
Fig. 6 Positive immunohistochemical reactions for 2
microglobulin are arrowed. Synovial fluid sediment
(A BC).
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Table 5 Localisation of amyloid deposits
Patient No
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Shoulder SF SF SF SF
Wrist SF SF SF SM
Knee SF/SM SF/SM SF/SM SF/SM SF/SM SM SF/SM SF SF SF
Ankle SF
Hip SM
Carpal tunnel* Bil. Bil. Bil. Bil. Bil. - Bil. Uni. Bil. Uni. Bil. Uni.
Fat - - - - - + + +
Echot _ +_
Other RB- RB+ RB+ RB- Colon Gastric
*Amyloid positive in annular ligament. synovium. or perineural region.
t+= suggestive of amyloid infiltration.
SF= synovial fluid; SM = synovial membrane; RB = rectal biopsy specimen.
Table 6 Identification of 2 microglobulin
Patient No Synovial fluid Synovial membrane
1 +
2 +
3 + wrist
4 + + hip
5 + + knee
7 +
10 + wrist
12 +
13 + (gastric)
14 + wrist
and gastric muscular layer (one patient) (Fig. 6,
Table 6). None of the control sections stained for P2
microglobulin.
Discussion
CLINICAL FEATURES
These 15 patients with CRF, after an average period
of seven years of haemodialysis, developed a
chronic arthropathy with joint pains or arthritis, or
both, in few or many joints, mainly shoulders,
knees, wrists, and fingers (tenosynovitis), though
any joints could be affected, together with carpal
tunnel syndrome (unilateral or bilateral) that tends
to relapse, thus requiring further surgery. This has
also been described by Brown et al.9 One of the
most consistent clinical signs was persistent swelling
of the knees or shoulders, or both. Joint effusions
were generally of the non-inflammatory type,
though some patients had acute crises with severe
inflammatory effusions.
Radiologically, geodes and erosions of variable
sizes were seen, which sometimes developed into a
destructive arthropathy.
The clinical and radiological picture is very similar
to the picture of amyloid arthropathy associated
with multiple myeloma.
The clinical pictifre that has been described in
several reports under diverse names: 'erosive
azotemic osteoarthropathy',8 'dialysis arthropathy',9
'arthropathy of long term haemodialysis',"' 'synovial
amyloidosis'"5 is similar to that of our patients with
proved amyloidosis. Although in some of these
publications the presence of amyloidosis was not
specifically looked for, it was present in the synovial
membrane in one patient reported by Brown et a19
and in three by Bardin et al,'5 and in carpal tunnel
structures in other series.'" 15 The presence of
erosions and geodes is a common feature in all these
reports, and these cannot be ascribed to secondary
hyperparathyroidism as some had these lesions with
normal parathyroid hormone (PTH) levels, whereas
others with lesions and abnormal PTH levels
showed no improvement on returning to normal
values.8 10 19 2(0 We therefore believe that in most of
these patients amyloidosis plays an important part. 13
'Destructive spondyloarthropathy' as described
by Kuntz et al,4 and attributed to the presence of
apatite crystals after these had been found in one
disc specimen, is probably part of the amyloid
arthropathy of CRFH. In favour of this is the
presence of amyloid in the disc or intervertebral
ligament, or both, in four patients described by
Sebert et al5 6 and the coincidence of destructive
spondyloarthropathy in four of our 15 patients with
amyloid arthro 5athy, in seven of 18 patients in
Bardin's series, 5 and in one of 15 patients reported
by Chattopadhay et al."'
Erosions and geodes are probably due to amyloid
bone invasion,' 1519 presumably spreading from
the synovium and could cause destructive arthritis in
shoulders, knees, and hips, and pathological frac-
tures of the hip, in particular the femoral
neck'2 14 21 22 as seen in two of our patients.
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Our experience leads us to believe that the
incidence of the different articular syndromes pre-
viously described in patients with CRFH,'21 namely
arthritis due to microcrystals (sodium urate, calcium
pyrophosphate. apatite. and oxalates). infections,
osteonecrosis, etc, is not very high. In a recent study
of 102 patients with CRFH. 23 had renal osteo-
dystrophy, five had periarticular calcifications, and
in only one patient was an apatite associated knee
arthritis' found, while the symptoms of 20 patients
with joint pains, three patients with polyarthritis,
and four with knee effusions remained un-
explained. It is probable that some of these patients
with partially unexplained symptoms might have
been affected by synovial amyloidosis; if so, then the
incidence of this condition may be very high.
EXTENSION OF AMYLOIDOSIS
In a previous study we mentioned the fact that
CRFH amyloidosis did not show evidence of mac-
roglossia, malabsorption syndrome. or car-
diomyopathy, and abdominal fat aspiration was
negative for amyloid in the six patients in whom it
was sought." This was confirmed by others in 30
patients with CRFH, 10 of whom also had a carpal
tunnel syndrome.24 In the present series three of 12
patients showed amyloid in the fat aspirate.
Other authors have not been able to find amyloid
in skin biopsy specimens (two patients),'4 necropsy
specimens (three patients) and a liver biopsy speci-
men (one patient),'9 rectal biopsy specimens (twopatients),' rectal and skin biopsy specimens (three
patients)25; all these patients, however, had amyloid
in joints or the carpal tunnel. Nevertheless other
reports indicate the possibility of systemic amyloido-
sis: positive rectal biopsy specimen in one patient,'5
and clinical signs of systemic amyloidosis (macro-
glossia with positive Congo red biopsy specimen,
heart failure, periorbital haematomas) in another
patient.26 In our series we found large depositions of
amyloid in the gastric muscularis layer in one patient
undergoing gastrectomy for a neoplasm, in the colon
mucus of a patient undergoing a hemicolectomy for
diverticulosis, and in two of four patients under-
going rectal biopsies (Table 5). Another patient who
had no articular symptoms and who is not included
in this series showed the presence of amyloid in
several organs (heart and prostate gland and in the
subendothelium of arterioles and small arteries of
the intestinal submucous membrane, heart, liver,
lung, testicles, and adrenal glands) at necropsy.
The echocardiogram performed in 12 patients
without cardiac symptoms showed changes com-
patible with amyloid infiltration in four.
In view of these observations we believe that
patients with CRFH can develop systemic amyloido-
sis, though in most the initial symptoms are confined
to the joints.
AMYL OlD CHARACTERISTICS
In all the patients in whom the staining characteris-
tics were studied by means of Wright's test"' a
congophilia resistant to potassium permanganate
was shown, which suggests that this was not AA
type amyloidosis, confirming our previous study."
The same characteristic has been indicated by other
authors) 1 27_2; in only two publications were the
staining characteristics those of AA type
amyloid.'3 14
Gejyo et al have shown that amyloid fibrils of a
patient with CRF had as their major component a
protein homologous with plasma 12 microglobulin,9
which would be consistent with our results when
using the permanganate test. Moreover, it seems
that both AL amyloid and 132 microglobulin amyloid
share the property of showing a congophilia resis-
tant to pretreatment with potassium permanganate,
and this may no longer be considered exclusively
indicative of the presence of AL amyloid.'" 34 132
Microglobulin is known to accumulate in the blood-
stream of patients with CRF,3' and haemodialysis is
unable to remove it from the plasma.) 132 Microglo-
bulin levels in serum do not seem to be a useful
marker for predicting the presence of amyloidosis in
CRFH as no significant differences have been found
between the values of P2 microglobulin in a group of
191 patients with CRFH having no carpal tunnel
syndrome and those of 10 patients with the
syndrome.32 We believe, however, that the persis-
tent and prolonged increase of 12 microglobulin in
these patients' serum is of great pathogenetic
significance. Connors et al showed that large
amounts of intact 02 microglobulin cause
fibrillogenesis.3"
Preliminary results obtained by immunohistoche-
mical techniques'6 from 10 of our patients con-
firm that the amyloid deposits contain 12 microglo-
bulin, a fact also reported by other authors.622 34
DIALYSIS MEMBRANES
12 Microglobulin kinetics vary according to the type
of membrane used. Patients undergoing dialysis
using a cuprophane membrane show higher values
than when using non-cellulose membranes (polysul-
phone, polyacrylonitrile).35-38 This increase was
partly related to haemoconcentration,38 though this
has been refuted on the grounds that the increase
occurs too early.39 It is significant that patients using
non-cellulose membranes do not seem to show
amyloid arthropathy21 and have a much lower
incidence of carpal tunnel syndrome.41
Given the possibility of amyloidosis occurring in
patients with CRFH, it would seem important to use
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a membrane that will ensure 12 microglobulin
excretion at as near to normal levels as possible (150
mg/day).
We would like to thank Dr A St J Dixon, Bath Institute for
Rheumatic Diseases. Bath. England. for kindly reviewing the
manuscript.
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